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The cataphoretic mobility-reducing action of the serums from patients with
pemphigus, dermatitis herpetiformis, disseminate lupus erythematosus and
erythema multiforme exudativum on the respective streptococci isolated from
patients with each of these diseases, as shown by comparison with the mobility
of these organisms in sodium chloride solution, was found to be so specific
in experiments already recorded (1, 2, 3, 4) that an attempt was made to apply
this action as a differential diagnostic test for these four diseases. The pre-
liminary results of these studies have already been reported (5). This report
deals with an analysis of the results of this test as applied to the serums of 322
patients.t
TECHNIC
Four antigens were used in this test. One consisted of a pooi of strains of
streptococci isolated from patients who had pemphigus, one consisted of a pool
of strains isolated from patients who had dermatitis herpetiformis, one consisted
of a pooi of strains isolated from patients who had disseminate lupus erythemato-
sus and another consisted of a pooi of strains isolated from patients who had
erythema multiforme exudativum. These streptococci were grown and stored
as single strains in the manner already described for the handling of streptococci
obtained from patients who had pemphigus, for the determination of catapho-
retic mobility in immune serums (1). The strains which were to be included in
the pooi used as the pemphigus antigen and which were isolated from patients
who had pemphigus were selected in the following manner. Each of these
strains was tested individually against the serums obtained from each of five
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patients who had pemphigus and against control serums obtained from patients
who had undisputed evidence of each of the other three diseases, by using the
technic described in the study just referred to. Only those strains whose
mobility was specifically reduced by the serum obtained from the patients who
had undisputed pemphigus, and whose mobility was not reduced by control
serums, were included in this pool. The strains which were included in the other
three pools used as the dermatitis herpetiformis, lupus erythematosus and
erythema multiforme antigens, were selected in each instance from the strains
isolated in the same manner from patients who had one of these diseases. Each
of these strains was tested with serums obtained from five patients who had the
respective disease, and using appropriate control serums. The pooled antigens
were diluted individually in triple distilled water, treated with formaldehyde,
corked, shaken and stored in the refrigerator, by using the methods described
in the investigations referred to previously.
The serums used for this study acted most specifically when the blood was
drawn, after a night of fasting, into sterile, dry syringes; transferred to sterile,
dry, chemically clean tubes, which were corked and stored in the refrigerator.
Fat, hemolysis, contamination, autolysis, heat and chemicals rendered these
serums unsatisfactory for testing. Some serums reduced equally and to a
moderate degree the mobility of all of the streptococci used in the tests. This
action was so marked with these serums as to render the test nondiagnostic.
On inquiry it was found that most of these serums had been obtained from pa-
tients to whom large quantities of arsenic had been administered. This action
might be attributable to the lowering of the surface tension of the globulin
particles in the serum by the arsenic. Recent experiments have shown that
inactivation of the serums (56°C. for twenty minutes), without altering the
specific action, removed in many instances most of the nonspecific effect on the
control antigens, which previously was manifested by serums drawn from pa-
tients who had an acute or toxic type of any of these four diseases. Inactivation
was unnecessary in many serums, particularly those from patients who were
suffering from the chronic form or a nontoxic phase of the disease, since under
these conditions there was little nonspecific effect. In serums which were stored
in the refrigerator for some weeks or months, much of the nonspecific effect
disappeared. This observation is consistent with the findings of E. Rosenthal,
in whose serologic studies fresh serums were found to possess a great deal of
nonspecific effect. In Rosenthal's (6) experiments, aging of the serum destroyed,
in most instances, the nonspecific action.
Each "set-up" consisted of four tubes, one containing 1 cc. of pooled pemphigus
antigen, another containing 1 cc. of the dermatitis herpetiformis antigen, another
containing 1 cc. of the lupus erythematosus antigen and the fourth containing
1 cc. of the erythema multiforme antigen. To each of these four suspensions
was added 1 cc. of the serum to be tested, which was diluted 1:320 with freshly
prepared, sterile 0.9 per cent solution of sodium chloride. This made the dilu-
tion 1:640 during incubation. If a negative test was obtained with all antigens
at this dilution, the test was repeated, and the dilution of the serum was only a
half that usually employed.
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The tubes were thoroughly shaken. Each "set-up" was incubated fourteen
minutes at 35°C., removed from the incubator, and 6 cc. of distilled water was
immediately added to each tube. The procedure followed to determine the
cataphoretic mobility of streptococci in each of these tubes has already been
described (1). The presence in a serum of antibodies for one of the antigens
was manifested by two phenomena: (1) the marked reduction of the mobility
of the streptococci in the pool of strains of streptococci constituting that antigen,
while the mobility of the streptococci in the other three pools was reduced equally
and little more than it was shown to be reduced by normal serum; (2) a char-
acteristic motion of the streptococci in the pool constituting that antigen, these
streptococci moved steadily at a constant speed toward the anode and at the
same time they seemed to roll or turn on themselves so that one surface after
another was presented toward the anode. This motion was in marked contrast
to that of the streptococci in the control pools. The latter moved in an even,
sliding manner without a tendency to turn or roll. This striking characteristic
motion of the streptococci which had been acted on by specific antibodies was
easily distinguished from the "jerky" motion provoked by introduction of
electrolytes into the system, in which circumstance the organisms seem to slide
forward without turning on themselves, only to stop and rapidly jerk backward
like a shuttle and then slide forward once more.
Figure 1 demonstrates the results of a typically positive test with the serum
obtained from (1) one patient who had pemphigus, (2) one who had dermatitis
herpetiformis, (3) one who had lupus erythematosus and (4) one who had cry-
thema multiforme. It is to be noted that each serum reduced markedly the
mobility of the streptococci in the pool of strains of streptococci isolated from
patients who had the respective disease, whereas it reduced the mobility of the
streptococci obtained from patients who had each of the other three diseases,
little or no more than did normal serum. The average mobility of the strepto-
cocci in the pools varied slightly from day to day. Normal serum reduced
slightly the mobility of all of the streptococci. The mobility of the nonspecific
streptococci was reduced slightly more in the pathologic serums than in normal
serum. This action is attributable to the presence of an increased amount of
globulin (7) in the pathologic serums.
To date, 34,872 individual readings, comprising 2,234 tests with 462 serums
obtained from 322 patients have been done. Two hundred and six of the pa-
tients had pemphigus, or dermatitis herpetiformis or disseminate lupus erythe-
matosus or erythema multiforme exudativum, while 116 had either normal
skins or were suffering from unrelated cutaneous or systemic diseases.
Analysis and consideration of the results of the test in cases of pemphigus
The tabulations in table 1 record the results of this test, together with the
available clinical data, as it has been applied as a diagnostic test for pemphigus.
Group A consists of the serums obtained in fifty-six cases in which the clinical
diagnosis of pemphigus was undisputed. A positive test was obtained with the
serum in each of these cases. In these fifty-six cases twenty-four patients died
of pemphigus subsequent to the time blood was drawn for testing. At the time
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of the last inquiry, the remaining thirty-two patients were alive and the disease
was in various states of clinical remission, relapse or progression. As is indi-
cated in this tabulation, positive tests were obtained with the serums of patients
who were suffering from the following forms of the disease: acute and chronic
types of pemphigus vulgaris, pemphigus vegetans, pemphigus foliaceus, Senear-
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FIG. 1. Typical reactions obtained with serum ia cases of pemphigus, dermatitis herpeti-
formis, lupus erythematosus and erythema multiforme.
Usher pemphigus, ocular pemphigus, and pemphigus that was limited to the
mucous membranes. If a positive reaction with this serologic test could be
considered a proof of the existence of this disease, several conclusions which are
supported by clinical observations could be drawn. First, all of the mentioned
clinical types are simply variations of the same disease process. Second, all
patients who contract the disease do not die of it, but a few apparently recover
(cases 106, 253, 287, 345). Third, pemphigus may begin with a syndrome which
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TABLE 1
Pemphigus vulgaris
Pemphigus vulgaris or ery.
thema multiforme
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Peniphigus vulgaris
Pemphigus vulgaris
Acute pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Acute pemphigus vulgaris
Pemphigus vulgaris
Bullous toxic erythema or
pemphigus
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Pemphigus vulgaris
Died of pemphigus, 9—24—34
Died of pemphigus 6 or 8 weeks after
onset.
Died of pemphigus, May, 1934.
Died of typical pemphigus
Died of pemphigus one week later
Died of pemphigus, November, 1934
Died of pemphigus; biopsy typical of
pemphigus; Pels' test toxic
Died of pemphigus, 8—11—34
Died of. typical pemphigus, 10—14—34
Died in fall of 1934 of typical pemphi-
gus; Pels' test 59 per cent—toxic
Died of pemphigus
Died of pemphigus, 9—6—34
Died of pemphigus, 2—3—35
Died of pemphigus 8 days later.
Died of peniphigus 3 weeks later.
Died of pemphigus, 11—27—35; Pels'
test 70 per cent—toxic
Died of pemphigus, 3—5—35; 12—14—34,
Pels' test 52 per cent—toxic, and
2—14—35,54 percent—toxic; positive
with pemphigus antigen, 2—19—35.
Died of pemphigus
Died of pemphigus, 6—4—35; Pels' test
toxic, three specimens
Died of pemphigus, November, 1935.
Died of pemphigus
Died of pemphigus, 11—28—35; Pels'
test toxic
Died one week later of pemphigus
Died of pemphigus, January, 1936.
4—4—36, lesions on body, scalp and
neck; Pels' test 53 per cent
2—5—36, some free periods but usually
lesions in eyes, mouth and vagina;
Pels' test toxic
11—6—35, completely blind; lesions of
eyes, mouth and throat; patient
never had skin lesions
6—1—35, in remission; no mouth lesions
past year; Pels' test toxic
6—15—35, patient in hospital; biopsy
typical of pemphigus foliaceous
Results of the diagnostic test for peniphigus
CASE
DATE ON
SERON WAS
RECEIVED
PHYSICIAN'S CLINICAL IMPRESSION EN
BLOOD WAS DRAWN SUBSEQUENT COURSE
Group A. Serums which were obtained in cases in which a definite clinical diagnosis
of pemphigus was made, and which produced positive tests with the pemphigus antigen.
3—26—34
2—12—34
4—19—34
6—19—34
6—26—34
7—26—34
7—26—34
8—8—34
8—8—34
8—13—34
8—20—34
8—20—34
9—4—34
8—19—34
9—26—34
11—17—34
12—17—34 Pemphigus vulgaris
60
107
147
165
173
181
182
199
202
203
212
214
227
233
238
250
257
298
332
366
373
397
432
435
38
61
82
106
108
3—27—35
4—16—35
7—24—35
8—2—35
10—4—35
10—29—35
11—19—35
4—28—33
7—22—33
9—28—33
2-12-34
2—15—34
Pemphigus; ocular and oral
Pemphigus vulgaris
Pemphigus foliaceous
TABLE 1—Continued
CASE SERUM WAS YSICIANLJ flSPRPSSION WREN SUBSEQUENT COUESE
Group A—Continued
110 2—15—34 Senear-Usher pemphigus 3—4—36, patient in hospital; clinical
evidence of Senear-Usher pemphi-
gus; 11—1—35, serum positive with
pemphigus antigen.
128 2—28—34 Pemphigus vulgaris 3—19—34, in relapse; skin and mouth
lesions; attack of foliaceous type,
1931; vulgaris type, September,
1935
131 3—13—34 Pemphigus vulgaris Lost contact with patient. Was clin-
ically typical pemphigus vulgaris
154 5—7—34 Pemphigus vulgaris 7—16—35, mucous membranes clear;
axillary lesions healing; clinically
pemphigus vegetans.
156 5—14—34 Pemphigus vulgaris 7—3—35, clinically pemphigus
163 6—2—34 Pemphigus or dermatitis her- 4—1—36, under treatment; new lesions
petiformis regularly; had stormy course; clini-
cally pemphigus.
167 6—21—34 Pemphigus foliaceous 3—31—35, some skin lesions; clinically
pemphigus foliaceous
169 6—22—34 Chronic pemphigus 6—7—35, improved; diagnosed pemphi-
gus by several dermatologists
180 7—19—34 Senear-Usher pemphigus Last seen October, 1934; then severe
pemphigus; diagnosed pemphigus
by several dermatologists.
200 8—9—34 Pemphigus vulgaris 3—18—36, in hospital; very weak; gen-
eralized eruption.
204 8—8—34 Pemphigus of conjunctiva 8—7—35, condition unchanged
245 11—3—34 Pemphigus foliaceous or ar- 3—28—36, in hospital; clinically pem-
senical dermatitis phigus
247 11—13—34 Pemphigus vulgaris 4—1—36, improved; April, 1934, clini-
cally Senear-IJsher pemphigus;
later, pemphigus vulgaris; Pels'
test 55 per cent—toxic. Nikoisky's
sign positive.
253 12—3—34 Senear-Usher pemphigus 4—14—36, in remission; 12—3—34, clini-
cally Senear-Usher peinphigus
281 2—18—35 Pemphigus vulgaris 5—6—36, confined to bed; typical severe
pemphigus
287 3—5—35 Oral pemphigus November, 1935, in remission; 3—5—35,
clinically classic pemphigus
297 3—27—35 Ocular and nasal pemphigus 3—2—36, eye lesions progressive; nose
improved; Pels' test toxic
344 4—1—36 Pemphigus vulgaris 3—30—36, in remission; treated by
Davis' method and mocassin
venom; Pels test toxic; 5—20—35,
serum positive only with dermatitis
herpetiformis antigen.
345 5—17—35 Pemphigus vulgaris 3—24—35, in remission; given Germanin
and had dental extractions; 3—20—36,
negative serum with pemphigus an-
tigen
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TABLE 1—Continued
Pemphigus vegetans or ery-
thema. multiforme
2—28—36, in hospital; failing; diag-
nosed pemphigus foliaceous at Min-
nesota Dermatological Society,
spring of 1935; diagnosed dermatitis
herpetiformis at University of Min-
nesota, 1927
3—28—36, typical pemphigus vegetans;
10—4—35, serum positive only with
erythema multiforme antigen, then
clinically pemphigus or erythema
multiforme; Pels' test toxic;
5—18—36, serum positive with pem-
phigus antigen
5—12—36, in partial remission; began
in mouth after dental extraction;
skin lesions six months later.
3—19—36, typical pemphigus, bullae in
mouth and pharynx; serum again
reacted positive with pemphigus
antigen
4—19—36, unchanged; Pels' test toxic;
diagnosis pemphigus by several
dermatologists
4-14—36, typical pemphigus foliaceous
Hospitalized; typical pemphigus vul-
garis
Hospitalized; typical pemphigus vul-
garis
CASE
DATE ON WRICR
SERIThS WAS
RECEIVED
PHYSICXAS'S CLINICAL rEPRESSION WHEN
BLOOD WAS DRAWN SDSEQUENT COORSE
Group A—Continued
Pemphigus foliaceous389
400
403
404
442
465
471
485
8—2—35
3—23—36
10—14—35
10—15—35
12—9—35
4—3—36
4—24—36
5—4—36
Pemphigus vulgaris
Oral pemphigus
Senear-Usher pemphigus
None given
Pemphigus vulgaris
Pemphigus vulgaris
Group B. Serums which were obtained in cases in which a definite clinical diagnosis
of peni phigus was made, and which produced negative tests with the pemphigus antigen.
149 4—29—34 Pemphigus foliaceous 7—19—34, died; no necropsy; probable
diagnosis, pemphigus; biopsy not
typical
222 8—25—34 Acute pemphigus,
multiforme or
medicamentosa
erythema
dermatitis
Blood drawn fifth day of illness; pa-
tient died on ninth day; necropsy—
cloudy swelling of parenchymatous
organs, bronchopneurnonia, septic
pulmonary infarcts—the picture of
intense toxemia.
Diagnosis, acute pemphigus.
Group C. Serums which were obtained in cases in which a clinical diagnosis of pemphi-
gus has not been established definitely, and which produced positive tests with pemphigus
antigen.
75 9—13—33 Pemphigus or dermatitis her- Observed at clinic eight months;
petiformis clinically pemphigus or dermatitis
herpetiformis; situation of lesions
favored pemphigus; no pruritus,
occasional bullae in mouth and nose
up to April, 1936. Four specimens
of blood positive with pemphigus
antigen.
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Pemphigus or erythema mul-
tiforme
Pemphigus or dermatitis her-
petiformis
Pemphigus vulgaris
Pemphigus vulgaris
Acute septic pemphigus
Acute septic pemphigus
Ocular pemphigus
Pemphigus or erythema mul-
tiforme
Vernal conjunctivitis and
aphthous stomatitis, or
ocular and oral pemphigus
Dermatitis herpetiformis or
pemphigus or bullous pyo-
derma
None given
11—19—35, in remission; dental foci re-
moved; occasional lesions first year.
3—4—36, clinically dermatitis herpeti-
formis or pemphigus; presented in
1928, Chicago Dermatological So-
ciety, with full blown pemphigus;
numerous Pels' tests toxic or bor-
derline
Lost
2—29—36, partial remission; occasional
bullae in umbilicus; 4—21—36, serum
positive with pemphigus antigen,
diagnosed pemphigus by four der-
matologists during attacks.
5—7—36, bedridden most of time, Ic-
brile; status of skin unknown; Pels'
test 54 per cent—toxic
3—5—36, in remission since Nov. 1935;
10—26—34, profound toxemia, clini-
cally severe pemphigus.
3—6—36, eye involvement stationary;
no skin lesions
3—19—35, clinically erythema multi-
forme or pemphigus; 3—22—35, toxic,
clinically pemphigus; stormy
course; left hospital in poor condi-
tion with generalized eruption;
Pels' test 67 per cent; March, 1936,
alive; status of skin unknown
October, 1935, slightly improved di-
agnosis at home, ocular and oral
pemphigus; March, 1936, improved;
lesions persist
3—28—36, clinically pemphigus or bul-
bus pyogenic eruption
3—24-36, mouth lesions characteristic
of pemphigus; skin lesions nonde-
script.
TABLE 1—Continued
CASE
DATE ON
SERUM WAS
RECEIVED
PHYSICIAN'S CLINICAL IMPRESSION WHEN1
BLOOD WAS DRAWN SUBSEQUENT COURSE
,
Group C—Continued
139
144
177
184
193
243
246
295
349
374
463
4—12—34
5—2—34
7—5—34
7—24—34
7—26—34
10—26—34
11—15—34
3—20—35
6—4—35
8—8—35
2—22—36
Group D. Serums which were obtained in cases in which the probable clinical diagnosis
was pemphigus, but which produced negative tests with pemphigus antigen and positive
tests with other antigens.
123 2—21—34 Pemphigus vulgaris (benign) * Lost; last seen 7—13—34; clinically un-
changed. Pels' test 67 per cent
124 2—21—34 Possible pemphigus* December, 1935, only one attack;
cured with viosterol; health good.
October, 1933, diagnosed pemphi-
gus at Minnesota Dermatological
Society.
* Antigen producing positive test: Dermatitis herpetifórmis.
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TABLE 1—Continued
CASE
DATE ON WUICR
SERUM WAS
RECEIVED
PHYSICIAN'S CLINICAL IMPRESSION WREN
BLOOD WAS DRAWN I SUBSEQUENT COURSEI
Group D—Continued
236 9—27—34 Pemphigus* 6—5—35, clear; recurrent fall attacks
three years; lesions only on dorsum
of hands and one eyelid; cleared on
intravenous injection of mercuro-
chrome 220; Pels' test 60 per cent
264 1—4—35 Dermatitis herpetiformis
pemphigus or erythema
multiforme*
3—28—36, died of bronchopneumonia;
diagnosed pemphigus by some and
dermatitis herpetiformis by others.
Two earlier serums obtained by an-
other doctor were positive with der-
matitis herpetiformis antigen
183 7—23—34 Senear-ljsher syndromef 4—2—36, died; positive blood culture
for hemolytic streptococci ante -
mortem; necropsy—septicemia,
chronic fibrous pleuritis, fatty vac-
uolization of liver, pyelonephritis;
skin clinically pemphigus
Group E. Serums which were obtained in cases in which the clinical diagnosis was not
pemphigus, but which produced positive test with pemphigus antigen.
155 5—11—34 Pemphigus vulgaris Last seen fall of 1934; dermatitis her-
petiformis favored; 5—11—34, gen-
eralized bullous eruption and mouth
lesions; positive Nikoisky's sign;
pemphigus favored; 10—29—34, se-
rum positive with pemphigus an-
tigen; died of pneumonia; no
autopsy; skin lesions present
170 6—23—34 None given 3—4—36, eruption persists; incapaci-
tated; last seen June, 1934; derma-
titis herpetiformis favored.
176 7—4--34 Pemphigus vulgaris or der- Last seen fall, 1934, dermatitis her-
matitis herpetiformis petiformis favored; lesions skin two
years; mouth five years. Diag-
nosed pemphigus by another der-
matologist.
427 10—20—35 Pemphigus? 3—4—36, diagnosed Vincent's angina;
alive, April, 1936, lesions cleared;
10—20—35, had ulceration of gums,
buccal mucosa and hard palate (two
years); recently spread downward,
weakness, fever, blebs in pharynx;
5—11—36, serum positive with pem-
phigus antigen.
f Antigen producing positive test: Lupus erythematosus.
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105
146
150
142
160
187
206
213
278
296
428
431
444
455
TABLE 1—Concluded
Bullous impetigo
Dermatitis medicamentosa
Dermatitis medicamentosa (amytal)
Idiopathic exfoliating dermatitis
Ulcer of the foot (etiology unde-
termined)
Sprue
Lymphatic leukemia
Dermatitis medicamentosa (phenol-
phthalein)
Submucous thrush
Malignant erythroderma
Dermatitis venenata with generalized
exfoliation
Recurrent vesicular eruption of
mouth and glans penis (etiology un-
determined); 3—4--36, well.
Beriberi
Aphthous stomatitis.
Herpes zoster
Recurrent herpes
Pityriasis rosea
Herpes facialis
Discoid lupus erythema-
tosus 9
Dermatitis mediamen-
tosa 6
Lichen planus 4
Infantile eczema 3
Infectious eczematoid
dermatitis 3
Pyoderma gangrenosum. 1
Pellagra 2
Angioncurotic edema.... 1
Atopic eczema 17
Varicella 4
tJrticaria 2
Cold allergy
Erythema nodosum.
Eczema of hands
Contact dermatitis.
Scieroderma
Neurodermatitis
Hodgkin's disease
Summer prurigo
Sarcoid
Acne rosacea
Toxic erythema (etiol-
ogy undetermined)..
Trichophytosis and tn-
chophytid (bullous)..
Ulcers of mouth (food
sensitivity) 1
Aphthous stomatitis 1
Normal persons 8
Rosacea-like tuberculid of
Lewandowsky 1
Erythema multiforme.... 34
Disseminate lupus cry-
thematosus (two re-
covered) 22
Dermatitis herpetiformis. 55
Herpes gestationes 5
Cases in which clinical di-
agnosis was not yet def-
initely established, all
of which were suspected
derniatitis herpeti-
I ormis 11
CASE
DATE ON WHICH
SERtThS WAS
RECEIVED
PHYSICIAN'S CLINICAL IMPRESSION WBN SUSEQURNT DIAGNOSISBLOOD WAS DRAWN
Group F. Serums which were obtained in cases in which a tentative clinical diagnosis
of pemphigus was entertained, but which produced negative tests with the pemphigus
antigen.
Group G. Serums obtained from patients who had diseases distinct from pemphigus
and from normal persons whose serums produced negative tests with pemphigus antigen.
9
4
5
2
1
1
1
2
4
1
1
1
1
2
1
3
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clincially and serologically is either dermatitis herpetiformis (case 344) or cry-
thema multiforme (case 400). Case 389 is also interesting from this standpoint.
In one case in which opportunity afforded (case 345) a test performed with
serum drawn long after clinical remission was negative, while during the attack a
positive test was obtained. This would seem to indicate that the patient had
completely recovered and, as in the case in other streptococcal diseases, the
antibodies gradually had disappeared from the blood. A positive test obtained
with serum drawn during a clinical remission might be interpreted as evidence
of the production of antibodies due to the continued presence of the organism
on the mucous surfaces or in foci of infection. Relapses might be expected in
such cases.
Group B consists of the serums obtained in two cases in which a definite
clinical diagnosis of pemphigus was made, but in which negative tests were
obtained with the pemphigus and control antigens. In case 149 all antigens
had their mobility reduced considerably more by this serum than by normal
serum. The effect was equal on each antigen. This effect on nonspecific anti-
gens has been seen with the serums obtained from patients who had been given
large quantities of arsenic before the blood was drawn for testing. A possible
explanation of this action already has been given. Determination has not been
made regarding administration of arsenic to the patient in this case. In regard
to case 222, the question of classification arises. Acute septic pemphigus of the
type that follows septic wounds or acute febrile diseases such as scarlet fever and
measles, or of the type that follows the handling of animal products or that
occurs after vaccination, occupies a doubtful position in the classification of true
pemphigus. Many authors believe acute pemphigus is distinct from the acute
form of pemphigus vulgaris and that it is essentially a septicemic process caused
by any one of several organisms varying in type from the hemolytic streptococci
to Escherichia coli. The literature on this subject has been reviewed thoroughly
by E. Riecke (8). If the patient representing case 222 had simply the acute
form of pemphigus vulgaris, then the failure of the test to demonstrate anti-
bodies in the blood may be explained by the fact that the blood used for testing
was drawn on the fifth day of an illness which caused death in nine days after
its onset, and it would seem reasonable that if any antibodies had been formed
in this short period during such an overwhelming infection, they were formed
in such a small quantity that they were not detectable by this method.
Group C consists of the serums obtained in twelve cases in which a clinical
diagnosis of pemphigus has not been established definitely. A positive test was
obtained, with the serum obtained in each of these cases. Contact with one of
these patients (case 177) has been lost. In cases 75, 139, 177, 184, 193, 243,
246, 295 and 463 (nine of the twelve) the clinical findings were those of pemphigus
at the time blood was drawn for testing. In none of these cases has pemphigus
been unquestionably ruled out clinically. Further observation of some of these
patients may settle the question of diagnosis. In those patients in which a
remission is present the diagnosis by clinical means cannot be definitely estab-
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lished if the remission continues. Repeated serologic studies will be made in
these cases.
In group D are included the serums obtained in five cases in which a clinical
diagnosis of pemphigus was favored but in which the serums produced negative
tests with the pemphigus antigen, and the tests with one of the control antigens
were positive. In four cases the tests with the dermatitis herpetiformis antigen
were positive and in the fifth case the test with the lupus erythematosus antigen
was positive. In case 103 the question of a pemphigoid type of lupus erythe-
matosus was raised.
Group E consists of the serums obtained in four cases in which a clinical diag-
nosis of pemphigus was not made but in which the blood serum gave a positive
test with the pemphigus antigen. In cases 155, 170 and 176 a clinical diagnosis
of dermatitis herpetiformis was favored. In case 427 a clinical diagnosis of
Vincent's angina was made. In this case blood serum which was drawn May 11,
1936 gave a positive test with the pemphigus antigen. The positive test ob-
tained during clincial remission suggested that the patient is still harboring the
organism, as antibodies were still demonstrable in her blood. Further study
of cases 170, 176, and 427 is desirable. It will be noted from analysis of groups
C, D, and E that when clinical diagnosis and laboratory diagnosis disagreed the
question of differentiation of pemphigus and dermatitis herpetiformis was
chiefly concerned. This is in accord with the difficulty encountered at times in
distinguishing clinically between these two dermatoses.
Group F includes the serums obtained in fourteen cases in which a tentative
clinical diagnosis of pemphigus was entertained but in which it eventually was
shown that the patients were suffering from disease totally unrelated to pemphi-
gus. All of these serums gave negative tests with the pemphigus antigen.
Group G consists of a control group of serums obtained from 229 patients who
had cutaneous or systemic diseases that were definitely distinct from pemphigus,
or who were well persons. Negative test with the pemphigus antigen was ob-
tained with each serum.
It is apparent that positive tests with the pemphigus antigen were obtained
with the serums obtained in seventy-two cases. In fifty-six of the cases (group
A) an undisputed clinical diagnosis of pemphigus was made, in twelve cases
(group C) a probable, but as yet not definitely established clinical diagnosis of
pemphigus was made, and in four cases (group E) a clinical diagnosis other than
pemphigus was made. Negative tests with the pemphigus antigen were obtained
with the serums drawn from 250 cases. In two cases (group B) a definite clinical
diagnosis of pemphigus was made but negative tests were obtained with all
antigens. In five cases (group D) a clinical diagnosis of pemphigus was favored,
but in four of these cases a positive test was obtained with the dermatitis herpeti-
formis antigen and in the fifth case a positive test was obtained with the
lupus erythematosus antigen. In fourteen cases (group F) pemphigus was
suspected on clinical grounds but in each instance it was later ruled out. In
229 cases (group G) the clinical diagnosis was definitely not pemphigus, but
various other cutaneous and systemic diseases were present.
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Analysis and consideration of the results of the test in cases of dermatitis herpetiformis
Table 2 shows tlt rcult this teat end th o.va.ilable clinical data in cases
of dermatitis herpetiformis. Group A consists of the serums obtained in fifty-
five cases in which the clinical diagnosis of dermatitis herpetiformis was definite.
A positive test was obtained with the dermatitis herpetiformis antigen in each
of these serums. In one instance (case 265) a serum drawn early in the course
of the disease produced a positive test with the erythema multiforme antigen
and a negative reaction with the dermatitis herpetiformis antigen and serum
drawn later in the course of the disease produced a positive test with the der-
matitis herpetiformis antigen and a trace of reaction with the erythema multi-
forme antigen. This raises the question whether or not the dermatitis at first
may begin as what is clinically and serologically erythema multiforme only to
change later to dermatitis herpetiformis. Considering the similarity of the re-
spective streptococci isolated from patients who have either of these two diseases,
such a possibility does not seem improbable.
Group B includes the serums obtained in five cases in which the clinical
diagnosis was herpes gestationes. Each of these serums produced a positive test
with the dermatitis herpetiformis antigen. This would seem to indicate that
these two dermatoses are identical in genesis. This impression is held by many
observers (9).
Group C includes the serums obtained in twelve cases in which the clinical
diagnosis of dermatitis herpetiformis has not been definitely established. Each
of these serums produced a positive test with the dermatitis herpetiformis an-
tigen. Contact with two of these patients (cases 336 and 234) has been lost.
In none of these cases has dermatitis herpetiformis been unquestionably ruled
out clinically. In most instances, clinical diagnosis of dermatitis herpetiformis
was favored at the time of the last follow-up. Analysis of the facts recorded in
the last column of the table shows that the differentiation clinically of dermatitis
herpetiformis and pemphigus most often was concerned. Further observation
of these patients may settle the diagnosis definitely.
Group D consists of the serums obtained in three cases in which a clinical
diagnosis of dermatitis herpetiformis was favored, but in which the serum pro-
duced a positive test with one of the control antigens, which in each instance was
the pemphigus antigen. Each of these patients was observed for only a short
time. One (case 155) died of pneumonia; no necropsy was performed. The
other two cases need further study. Again, the question of clinical differentia-
tion of dermatitis herpetiformis and pemphigus is concerned.
Group E consists of the serums obtained in three cases in which a clinical
diagnosis of dermatitis herpetiformis was not made, but in which the serums
produced a positive test with the dermatitis herpetiformis antigen. In each
instance the clinical impression favored the diagnosis of pemphigus. Contact
with one of these patients (case 123) has been lost. The subsequent course of
the other two is recorded. It is interesting that each patient had only one attack
and that complete recovery ensued.
Group F includes the serums obtained in six cases in which a tentative clinical
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TABLE 2
Results of the diagnostic test for dermatitis herpetiformis
CASE
DATE °N
SERUH WAS
RECEIVED
PHYSICIAN'S CLINICAL Th&RESSION WHEN SUBSEQUENT COURSEBLOOD WAS DRAWN
Group A. Serums which were obtained from cases in which a definite clinical diagnosis
of dermatitis herpetiformis was made, and which produced positive tests with dermatitis
herpetiformis antigen.
1—27—33 Dermatitis herpetiformis 4—17—36, clinically dermatitis herpet-
iformis; serum again positive with
dermatitis herpetiformis antigen;
positive to potassium iodide by
mouth and by patch.
21 3—14—33 Dermatitis herpetiformis 8—12—34, eruption still present; posi-
tive to potassium iodide by patch
and by mouth; duration four years.
80 9—26—33 Dermatitis herpetiformis 3—10—36, clinically dermatitis herpeti-
I ormis; positive patch to potassium
iodide.
81 9—28—33 Dermatitis herpetiformis 7—18—34, in acute flare-up of dermati-
tis herpetiforms; positive patch to
potassium iodide.
83 9—28—33 Dermatitis herpetiformis 2—7—36, clinically dermatitis herpeti-
formis; serum again positive with
dermatitis herpetiformis antigen;
positive patch to potassium iodide.
109 2—12—34 Dermatitis herpetiformis 6—28—35, clinically dermatitis herpet-
iformis.
112 2—14—34 Dermatitis herpetiformis 6—5—35, having cyclic recurrences of
dermatitis herpetiformis.
113 2—15—34 Dermatitis herpetiformis 6—5---35, clinically dermatitis herpeti-
formis; began in mouth; 7—30—34,
serum positive with dermatitis
herpetiformis antigen.
119 2—19—34 Dermatitis herpetiformis 6—3—35, clinically dermatitis herpeti-
formis; now twenty-one years old,
began at six.
136 4—6—34 Dermatitis herpetiformis 12—3—34, clinically dermatitis herpet-
if ormis; positive patches to potas-
sium iodide and potassium bro-
mide.
151 4—30—34 Dermatitis herpetiformis 6—5—35, typical dermatitis herpeti-
formis; twenty-five years' dura-
tion.
153 5—7—34 Dermatitis herpetiformis 6—3—35, clinically dermatitis herpeti-
formis.
164 6—11—34 Dermatitis herpetiformis 4—28—35, dermatitis herpetiformis still
present; 8—19—35, serum positive
with dermatitis herpetiformis an-
tigen.
171 7—5—34 Dermatitis herpetiformis 7—19—35, clinically dermatitis herpeti-
formis.
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TABLE 2—Continued
2—29—36, clinically dermatitis herpet-
iformis.
7—31—35, dermatitis herpetiformis
present; positive patch to potas-
sium iodide.
7—25—34, clinically dermatitis herpet-
iformis; Lost.
2—9—36, dermatitis herpetiformis pres-
ent; positive patch to potassium
iodide.
6—5—35, typical course dermatitis her-
petiformis; duration eight years;
died of pneumonia, January, 1935.
12—7—34, dermatitis herpetiformis still
present.
10—25—35, clinically dermatitis herpet-
iformis when last seen.
5—4—35, cyclic recurrences dermatitis
herpetiformis; positive patch to
potassium iodide; duration six
years.
10—22—35, clinically dermatitis herpet-
if ormis when last seen.
10—15—35, clinically dermatitis herpet-
iformis; duration nine years.
10—15—35, clinically dermatitis herpet-
if ormis.
10—25—35, clinically dermatitis herpet-
iformis, when last seen; attacks for
twenty years.
10—15—35, typical dermatitis herpeti-
formis
10—25—35, clinically dermatitis herpet-
formis when last seen.
3—5—35, in flare of dermatitis herpeti-
I ormis
3—4—36, typical dermatitis herpeti-
formis. Died, 1935, of pneumonia
3—24—36, typical dermatitis herpeti-
formis. Serum again positive with
antigen
5—21—35, cyclic flares of dermatitis
herpetiformis
3—28—36, dermatitis herpetiformis; cy-
clic flares; 1—10—35, serum positive
only with erythema multiforme
antigen.
DATE ON WHICH
CASE SERUM WAS
RECEIVED
PHYSICIAN'S CLINICAL IMPRESSION WHEN
BLOOD WAS DRAWN SUBSEQUENT COURSE
Group A—Continued
174
178
186
189
195
196
201
215
216
217
218
219
220
221
223
231
232
242
265
7—26—34
7—12—34
7—25—34
7—27—34
7—31—34
8—1—34
8—8—34
8—23—34
8—21—34
8—21—34
8—21—34
8—21—34
8—21—34
8—21—34
8—29—34
9—15—34
9—17—34
10—19—34
4—16—36
None given
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Pemphigus or dermatitis her-
petiformis
None given
Dermatitis herpetiformis
Erythema multiforme
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TABLE 2—Continued
3—28—36, typical dermatitis herpeti-
formis; positive patch to potassium
iodide
3—4—36, typical dermatitis herpeti-
formis
8—5—35, typical dermatitis herpeti-
formis
Lost; typical dermatitis herpeti-
formis; 5—8—35, positive patches to
potassium iodide and potassium
bromide
9—26—35, typical dermatitis herpeti-
formis; positive patch to potassium
iodide
5—28—36, typical dermatitis herpeti-
formis; flare from potassium iodide
by mouth; lesions of mouth and
vulva; 2—26—36, serum positive with
dermatitis herpetiformis antigen
7—15—35, clinically dermatitis her-
petiformis; lost; positive patch to
potassium iodide
3—4—36, clinically dermatitis herpeti-
formis; positive patches to potas-
sium iodide and potassium bromide
2—17—36, cyclic flares of dermatitis
herpetiformis; negative patch to
potassium iodide and potassium
bromide; flared by potassium bro-
mide by mouth.
9—26—35, clinically dermatitis herpeti-
formis; lost; positive patches to po-
tassium iodide and potassium bro-
mide.
3—9—36, dermatitis herpetiformis;
11—15—35, serum positive with der-
matitis herpetiformis antigen.
4—10—36, typical dermatitis herpeti-
formis; positive patch to potassium
iodide
3—9—36, typical dermatitis herpeti-
formis positive patches to potas-
sium iodide and potassium bro-
mide; flare from potassium iodide
orally.
1—8—36, typical dermatitis herpeti-
formis; lost; positive patch to p0-
tassium iodide.
CASE
DATE ON WHICH
SERUM WAS
RECEIVED
pnVsICI.s's CLINICAL IMPRESSION WHEN
BLOOD WAS DRAWN SUBSEQUENT COURSE
Group A—Continued
266
269
275
343
356
363
364
390
392
396
429
434
445
448
1—10—35
1—16—35
2—1—35
5—8—35
6—26—35
7—15—35
7—15—35
9—6—35
9—15—35
9—26—35
10—21—35
11—11—35
12—20—35
1—8—36
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
Possibly pemphigus
Dermatitis herpetiformis
Dermatitis herpetiformis
Dermatitis herpetiformis
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TABLE 2—Continued
CASE
DATE ON WHI PHYSrCIAN'S CLINICAL WPRESSION SmSEQUENT COURSE
Group A—Continued
456 3—10—36 Dermatitis herpetiformis or
erythema multiforme
5—13—36, typical dermatitis herpeti-
formis; positive patch to potassium
iodide.
457 3—16—36 None given 3—24—36, clinically dermatitis herpeti-
formis
460 3—18—36 Dermatitis herpetiformis 3—18—36, clinically dermatitis herpeti-
formis; Lost
462 3—20—36 Dermatitis herpetiformis 3—20—36, typical dermatitis herpeti-
formis; twenty years' duration;
positive patch to potassium iodide.
468 4-15—36 Dermatitis herpetiformis Now at clinic; typical dermatitis her-
petiformis
473 4—27—36 None given 5—12—36, typical dermatitis herpeti-
formis.
486 5—5—36 Dermatitis herpetiformis or
dermatitis medicamentosa
Typical dermatitis herpetiformis;
flared by potassium iodide by
mouth; diagnosed pemphigus one
and a half years ago by home doctor
331 4-1—35 Dermatitis herpetiformis or
erythema multiforme
Flared, June, 1935. On 9—15—35 olin-
ically dermatitis herpetiformis;
positive patch to potassium iodide;
responded to arsenic
Group B. Serums which were obtained in cases in which the clinical diagnosis was
herpes gestationes, and which produced positive tests with dermatitis herpetiformis an-
tigen.
__________________________________
125* 2—23—34 Herpes gestationes 6—3—35, clinically herpes gestationes;
cleared after delivery
152 5—6—34 Herpes gestationes June, 1935, cleared following delivery;
no recurrence; typical herpes gesta-
tiones
240* 10—9—34 Herpes gestationes or pem- 3—3—36, well since December, 1934;
phigus vesicular eruption grouped like der-
matitis herpetiformis; positive
Nikolsky's sign; few mouth lesions
three weeks before she had a mis-
carriage at the eighth month;
stormy course; Pels' test 65 per
cent.
262 12—31—34 Herpes gestationes 5—7—36, clinically herpes gestationes
386 8—26—35 Herpes gestationes 2—28—36, clinically dermatitis herpeti-
formis; persisted two months after
delivery; one recurrence.
* Serum diluted 1:320 instead of using dilution of 1:640.
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TABLE 2—Continued
CASE SERtOS WAS PUSICIANS CLINICAL INPRESSION WBEN SUBSEQUENT COURSE
Group C. Serums which were obtained in cases in which a clinical diagnosis of dermatitis
herpetiformis has not been definitely established, but which produced positive tests with
dermatitis herpetiformis antigen.
235 9—24—34 Dermatitis herpetiformis or Seen daily two years; recurrent urti-
erythema multiforme canal, erythematous lesions on el-
bows; pruritus; positive to potas-
sium iodide by patch and by mouth,
with vesicles; 2—13—36, serum posi-
tive with dermatitis herpetifornais
antigen.
264 1—4—35 Dermatitis herpetiformis, Two earlier specimens from another
pemphigus or erythema source gave positive tests with der-
multiforme matitis herpetiformis antigen; pa-
tient died of bronchopneumonia;
diagnosis, pemphigus or dermatitis
herpetiformis
271 1—12—35 Dermatitis herpetiformis or 2—20—36, well; clinically dermatitis
pemphigus herpetiformis "with possibility of
eventuating in penaphigus"
336 4—22—35 Dermatitis herpetiformis; Lost; 4—22—35, duration forty years;
features of pemphigus grouped vesicles; sharp burning;
eosinophilia; good health; negative
patch to potassium iodide; positive
Nikolsky's sign
368 7—26—35 Dermatitis herpetiformis, 5—6—36, clinically dermatitis herpeti-
pemphigus or erythema formis; 7—26—36, dermatitis herpeti-
multiforme formis or pemphigus, cleared; re-
lapsed; pruritus
447 1—8—36 Pemphigus foliaceous 5—1—36, cleared once; relapsed; now
improved; a typical dermatitis her-
petiformis
118 2—17—34 Probably dermatitis herpeti- 6—5—35, clinically dermatitis herpeti-
formis. Pemphigus? formis; negative Nikolsky's sign
five years' duration
166 6—22—34 Pemphigus; bullous iodo- 3—28—36, clinically dermatitis herpeti-
derma; bullous erythema I orinis; possibility of chronic ec-
multiforme zema; itching eruption in patches;
no hullous lesions since first acute
outbreak
229 9—10—34 None given 4—24—36, well; skin clear; dermati-
tis herpetiformis or pemphigus;
9—10—34, cleared; recurred in 1935.
234 9—19—34 Dermatitis herpetiformis or Lost; dermatitis herpetiformis I a-
pemphigus vnred clinically 9—19—34
248 11—16—34 Pemphigus or dermatitis her- 4—1—36, in recurrence; grouping of der-
petiformis matitis herpetiformis; crops of le-
sions; pruritus; good physically;
had mouth lesions.
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TABLE 2—Continued
I DATE ON WEICU
CASE SERUM WAS
RECEIVE!)
PHYSICIAN'S CLINICAL IMPRESSION WHEN
BLOOD WAS DRAWN SUBSEQUENT COURSE
Group C—Continued
360 4—19—36 Bullous lupus erythematosus? 4—7—36, dermatitis herpetiformis I a-
vored; diagnosis not definitely es-
tablished; 7—5—35, serum negative
with dermatitis herpetiformis an-
tigen.
Group D. Serums which were obtained in cases in which the clinical diagnosis was
dermatitis herpetiformis, but which produced negative tests with dermatitis herpeti-
I ormis antigen and positive tests with other antigens.
3—4—36, eruption persists; last seen
June, 1934; then dermatitis herpeti-
formis favored; biopsy favored der-
matitis herptiformis
Last seen fall of 1934 when dermatitis
herpetiformis was favored; lesions
of skin two years and mouth five
years; diagnosed pemphigus by an-
other dermatologist. 8—13—34, se-
rum positive with pemphigus an-
tigen; alive April, 1936.
Last seen fall of 1934, dermatitis her-
petiformis favored; 5—11—34, gen-
eralized bullous eruption with
mouth lesions; positive Nikolsky's
sign; pemphigus favored; 10—29—34,
serum positive with pemphigus an-
tigen; recently died of pneumonia;
no necropsy.
Group E. Serums which were obtained in cases in which the clinical diagnosis was not
dermatitis herpetiformis, but which produced positive tests with dermatitis herpetiformis
antigen.
123 2—21—34 Pemphigus (benign) Lost; 7—13—34, unchanged; Pels' test
67 per cent
124 2—21—34 Pemphigus? December, 1935, cleared on viosterol;
health good
236 9—27—34 Pemphigus (benign) 6—5—35, clear; attacks for three years,
limited to dorsum of hands and one
eyelid; cleared on intravenous in-
jection of mercurochrome 220; Pels'
test 60 per cent.
None given170
176
155
6—23—34
7—4—34
5—11—34
Pemphigus vulgaris
Pemphigus vulgaris
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TABLE 2—Concluded
Herpes zoster
Recurrent herpes
Pityriasis rosea
Herpes facialis
Discoid lupus erythema-
tosus
Dermatitis medicamen-
tosa 9
Lichen planus 4
Infantile eczema 3
Infectious eczematoid
dermatitis I
Pyoderma gangrenosurn. 1
Pellagra 2
Angioneurotic edema.... 1
Atopic eczema 17
Varicella 4
Urticaria 2
Ulcers of mouth (food
sensitivity) 1
Trichophytosis with tn-
chophytid 3
Lymphatic leukemia.... 1
Cold allergy
Erythema nodosum....
Eczema of hands
Contact dermatitis.
Seleroderma
Bullous impetigo
Sprue
Thrush
Beriberi
Sane oid
Acne rosacea
Aphthous stomatitis...
Vincent's angina
Vesicular toxic ery-
thema (etiology un-
determined)
Recurrent vesicular
eruption of mouth
and penis (etiology
undetermined)
Normal persons
Idiopathic exfoliative der-
matitis 1
Ulcer of foot (etiology un-
determined) 1
Malignant erythroderma. 1
Dermatitis exfoliativa
venenata 1
Rosacea-like tuberculid
(Lewandowsky) 1
Pemphigus 58
Lupus erythematosus (two
recovered) 22
Erythema multiforme.... 34
Cases in which clinical
diagnosis was not defi-
nitely established, but
in which pemphigus was
suspected 13
diagnosis of dermatitis herpetiformis was entertained, but in which it eventually
was shown that the patients were suffering from diseases totally unrelated to
dermatitis herpetiformis. All of these serums produced negative tests with
dermatitis herpetiformis antigen and control antigens.
Group G consists of a control group of serums obtained from 238 patients
who were well or who had cutaneous or systemic diseases definitely distinct from
dermatitis herpetiformis. A negative test with the dermatitis herpetiformis
antigen was obtained with each of these serums.
It is apparent that positive tests with dermatitis herpetiformis antigen were
DATE ON WHICH
CASE SERUM WAS PHYSICIAN'S CLINICAL IMPRESSION WHEN
RECEIVED BLOOD WAS DRAWN
FINAL DIAGNOSIS
Group F. Serums obtained in cases in which a tentative clinical diagnosis of dermatitis
herpetiformis was entertained, but which produced negative tests with dermatitis herpeti-
formis antigen.
191 Neurodermatitis
211 Hodgkin's disease with bullae
357 Summer prurigo
379 Infectious eczematoid dermatitis
452 Infectious eczematoid dermatitis
472 Atopic eczema
Group G. Serums obtained in diseases distinct from dermatitis herpetiformis and from
normal persons, and which produced negative tests with dermatitis herpetiformis antigen.
9
4
5
2
9
1
1
1
1
4
1
1
1
1
1
2
2
1
1
1
8
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obtained with the serums in seventy-five cases, in fifty-five of which (group A)
an undisputed clinical diagnosis of dermatitis herpetiformis was made, in five of
which (group B) a clinical diagnosis of herpes gestationes was made, in twelve of
which (group C) a probable but as yet not definitely established clinical diagnosis
of dermatitis herpetiformis was made, and in three of which (group E) a clinical
diagnosis other than dermatitis herpetiformis was made. Negative tests with
the dermatitis herpetiformis antigen were obtained with the serums in 247 pa—
tients. In three of these cases (group D) a clinical diagnosis of dermatitis
herpetiformis was favored but a positive test with the pemphigus antigen was
obtained in each instance. In six cases (group F) dermatitis herpetiformis was
suspected clinically but was later ruled out. In 238 cases (group G) the clinical
diagnosis was definitely not dermatitis herpetiformis but any one of various
other cutaneous and systemic diseases.
Analysis and consideration of the results of this test as applied to lupus erythernatosus
Table 3 shows the results of this test, together with the available clinical data,
as it has been applied as a diagnostic test for lupus erythematosus. Group A
consists of the serums from twenty patients in whom the clinical diagnosis of
disseminate lupus erythematosus is definitely established. A positive test with
lupus erythematosus antigen was obtained with the serum. from each of these
patients. In one patient (138) the clinical picture at the time the serum was
drawn was that of the Senear-Usher type of pemphigus.
Group B consists of the serum from a patient in whom the clinical diagnosis
at the time the serum was drawn was Senear-Usher type of pemphigus. As is
noted in the table, this patient subsequently died of a hemolytic streptococcic
septicemia. The cutaneous picture at the time of death was that of pemphigus
vulgaris. This serum gave a positive test with the lupus erythematosus antigen
and negative tests with the control antigens. In this case the question of a
pemphigoid type of lupus erythematosus is raised.
Group C includes the serums which were obtained from two patients who had
recovered from subacute disseminate lupus erythematosus. In case 286 the
serum was drawn three years after recovery and in case 450 it was drawn four
years after recovery. Both of these serums produced negative tests with the
lupus erythematosus antigen and control antigens. Apparently, in the event
of complete recovery, the antibodies responsible for the reduction of the mobility
of the specific streptococci are lost.
Group D includes the serums obtained in eleven cases in which a tentative
clinical diagnosis of disseminate lupus erythematosus was entertained. It
was eventually shown that six of these patients were suffering from diseases
wholly unrelated to lupus erythematosus and that five had the discoid type of
lupus erythematosus. All of these serums produced negative tests with the
lupus erythematosus antigen and control antigens. At half dilution there was a
slight reduction of the mobility of the streptococci comprising the lupus cry-
thematosus antigen by some of the serums of patients who had lupus erytherna-
tosus discoides.
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TABLE 3
Results of the diagnostic test for lupus erythematosus
CASE
DATE ON WWICH
SERUM WAS
RECEIVED
PHYsICIAN'S CLINICAL INPRYSSION SUBSEQUENT COURSEWREN BLOOD WAS DRAWN
!
Group A. Serums which were obtained in cases in which a clinical diagnosis of dis-
seminate lupus erythematosus was established, and which produced positive tests with
lupus erythematosus antigen.
68 8—10-33 Subacute disseminate lupus 11—21—35, lesions of face and scalp
erythematosus
72 9—12—33 Subacute disseminate lupus 8—24—35, health good; lesions
erythematosus around mouth
77 9—19—33 Subacute disseminate lupus Died 9—17—34, autopsy; lupus ery-
erythematosus thematosus, bronchopneumonia,
glomerulonephritis and pericar-
ditis; 9—28—33 serum positive with
lupus erythematosus antigen
87 10— 5—33 Acute disseminate lupus Died of acute lupus erythematosus
erythematosus
133 4— 2—34 Disseminate lupus ery- 8—14—35, treated for lupus ery-
theniatosus thematosus; improved.
138 4—11—34 Senear-Ilsher syndrome 6—3—35, clinically lupus ery-
thematosus
168 6—22—34 None given 2—29—36, subacute lupus erythema-
tosus; good condition; pigmenta-
tion and alopecia
179 7—16—34 Subacute disseminate lupus 10—28—34, skin lesions; clinically
erythematosus typical subacute lupus erythema-
tosus
197 8— 3—34 Subacute disseminate lupus 8—5—35, no active lesions; foci re-
erythematosus moved; on quinine.
198 8— 6—34 Disseminate lupus ery- 10—15—35, treated for lupus ery-
thematosus thematosus; improved, leuko-
penia
208 8—20—34 Subacute disseminate lupus 6—15—35, improving on gold; typical
erythematosus lupus erythematosus.
228 9— 7—34 Subacute disseminate lupus 1—13—36, improved; typical lupus
erythematosus erythematosus.
282 2—20—35 Subacute disseminate lupus 4—11—36, improved; relapsed March,
erythematosus 1936. Typical lupus erythema-
tosus disseminate.
367 7—26—35 Subacute disseminate lupus 3—3—36, improved; typical lupus
erythematosus erythematosus.
369 7—27—35 Subacute disseminate lupus Typical subacute lupus erythema-
erythematosus tosus. Last seen 9—20—35.
375 8—12—35 Acute disseminate lupus 1—10—36, quite ill with lupus cry-
erythematosus thematosus
381 8—21—35 Acute disseminate lupus Died 11—6—35, of acute lupus cry-
erythematosus thematosus
436 11—19—35 Subacute disseminate lupus 6—20—36, in hospital; generalization
erythematosus after gold; biopsy typical sub-
acute disseminate lupus cry-
thematosus
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TABLE 3—Continued
I DATE ON WHICH I PHYSICIAN'S CLINICAL IMPRESSIONCASE I 511GM WAS I WHEN BLOOD WAS DRAWNRECEIVED
I
SUBSEQUENT COURSE
Group A—Continued
437
487
11—19—35
5—13—36
Subacute disseminate lupus
erythematosus.
Acute disseminate lupus
erythematosus
1—9—36, bedfast; quite ill with
lupus erythematosus
5—23—36, died of acute disseminate
lupus erythematosus
Group B. Serum which was obtained in a case in which the clinical diagnosis was
Senear-Usher syndrome, but which produced a positive test with lupus erythematosus
antigen.
183 7—23—34 Senear-TJsher syndrome 4—21—36, died; positive blood cul-
ture for hemolytic streptococci,
antemortem; necropsy—chronic
fibrous pleuritis, fatty vacuoliza-
tion of liver and pyelonephritis;
skin clinically pemphigus
Group C. Serums which were obtained in two cases in which the patients recovered
from definite lupus erythematosus disseminatus, but which produced negative tests with
the lupus erythematosus antigen.
286 3— 5—35 Subacute disseminate lupus 1930, subacute disseminate lupus
erythematosus erythematosus; confirmed by
biopsy; recovered; clear for
three years.
450 1—29—36 Subacute disseminate lupus
erythematosus
4—19-32, typical acute disseminate
lupus erythematosus; biopsy
quite typical; recovered; clear
for three years.
Group D. Serums which were obtained in cases in which a tentative clinical diagnosis
of disseminate lupus erythematosus was entertained, but which produced negative tests
with the lupus erythematosus antigen.
LINAL DIAGNOSIS
8 Sarcoids
78 Atopic eczema
130 Acne Rosacea
148 Acne rosacea
185 Discoid lupus erythematosus
209 Discoid lupus erythematosus
210 Discoid lupus erythematosus
337 Discoid lupus erythematosus
395 Discoid lupus erythematosus
466 Rosacea-like tuberculid of
Lewandowsky
467 Henoch's purpura
Herpes zoster . 9
Recurrent herpes 4
Pityriasis rose a 5
Herpes facialis 2
Discoid lupus ery-
thematosus 4
Dermatitis medica-
mentosa 9
Lichen planus 4
Infantile eczema 3
Infectious eczematoid
dermatitis 3
Pyoderma gangrenosum. 1
Pellagra 2
Angioneurotic edema.... 1
Atopic eczema 16
Recurrent vesicular
lesions of mouth and
penis (etiology un-
determined) 1
Malignant erythro-
derma 1
Varicella
Urticaria
Cold allergy
Erythema nodosum....
Eczema of hands
Contact dermatitis.
Schieroderma
Neurodermatitis
Hodgkin's disease
Summer prurigo
Trichophytosis with
trichophytid
Ulcers of the mouth;
food sensitivity
Aphthous stomatitis...
Beriberi
Dermatitis exfoliativa
(venenata)
Thrush
Sprue
Lymphatic leukemia 1
Ulcer of foot—(etiology
undetermined) 1
Idiopathic exfoliative
dermatitis 1
Bullous impetigo 1
Vincent's angina 1
Pemphigus 58
Dermatitis herpeti-
formis 55
Herpes gestationes 5
Erythema multiforme.. 34
Normal persons 8
Cases in which clinical
diagnosis was not yet
definitely established.
(Pemphigus was sus-
pected in 15 and der-
matitis herpetiformis
in 15) 30
Group E consists of a control group of serums of 288 patients, 284 of whom
were well or had cutaneous or systemic diseases definitely distinct from dis-
seminate lupus erythematosus and four of whom had the chronic discoid type of
lupus erythematosus. A negative test with the lupus erythematosus antigen
was obtained with each of these serums.
It is evident that positive tests with the lupus erythematosus antigen were
obtained with the serums obtained in twenty-one cases. In twenty cases (group
A) a definite clinical diagnosis of disseminate lupus erythematosus was estab-
lished, and in one case (group B) a clinical diagnosis of pemphigus was made.
Negative tests with the lupus erythematosus antigen were obtained with the
serums in 301 cases. In two of these (group C) the serums were drawn from
patients who had recovered from subacute disseminate lupus erythematosus
three and four years respectively before the test was performed. In eleven
cases (group D) disseminate lupus erythematosus was suspected clinically but
was later ruled out. In the remaining 288 cases (group E) the clinical diagnosis
was definitely not disseminate lupus erythematosus but any of various other
cutaneous and systemic diseases. Groups D and E comprise the serums from
five patients and four patients respectively who had the chronic discoid type of
lupus erythematosus. Very weakly positive tests with the lupus erythematosus
antigen were obtained with five of these nine serums, but only when they were
tested at half the usual dilution of serum. From these results it must be con-
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TABLE 3—Concluded
Group E. Serums which were obtained in diseases unrelated to disseminate lupus ery-
thematosus, discoid lupus erythematosus, and from normal persons, and which produced
negative tests with lupus erythematosus antigen.
4
2
1
1
1
2
4
1
1
1
3
1
2
1
1
1
1
TABLE 4
Results of the diagnosis lest for erythema mull if orme
DATE ON WHICH
CASE SERIM WAS
REcEIVED
PHYSICIAN'S CLINICAL nSPRESSION WHEN
BLOOD WAS DSAWN SUESQUENT COUESE
Group A. Serums which were obtained in cases in which a clinical diagnosis of erythema
multiforme exudativum was established, and which produced positive tests with erythema
multiforme antigen.
Erythema multiforme
Erythema multiforme or
pemphigus
Herpes gestationes or ery-
thema multiforme
Erythema multiforme
Erythema multiforme
Erythema multiforme and re-
current herpes
Erythema multiforme
Erythema multiforme or
pemphigus
Erythema multifornie
Erythema multiforme or der-
matitis medicamentosa
Erythema multiforme
6—13—35, no recurrence; clinically ery-
thema multiforme.
3—24—36, clinically erythema multi-
forme; no recurrence.
8—2—34, recurrence, typical erythema
multiforme; Pels' test 75 per cent—
non-toxic; 8—2—34, serum positive
with erythema multiforme antigen.
7—3—35, not seen recently; clinically
erythema multiforme.
6—2—36, typical erythema multiforme;
no recurrence.
6—15—35, typical course of erythema
multiforme.
6—5—35, not seen recently; clinically
erythema multiforme.
June, 1935, recurrence followed ex-
traction of teeth; well then.
3—27—36, ran course of erythemamul-
tiforme; no recurrence; 8—2—35, se-
rum negative with all antigens.
6—5—35, had typical erythema multi-
forme.
October, 1935, typical course of ery-
thema multiforme; well then.
6—19—36, recurrence, again pregnant;
began during pregnancy; fifth at-
tack; Pels' test 53 per cent—toxic.
4—6—36, typical bullous erythema mu!-
tiforme; no recurrence
3—28—36, typical erythema multi-
I one; several attacks.
4—9—36, cyclic recurrences of erythema
multiforme preceded by recurrent
herpes of buttocks; 4—9—36, serum
positive with erythema multiforme
antigen.
5-15-35,110 recurrence; spring and fall
attacks 6 years.
4—14—36, favored erythema multi-
forme; not seen recently.
October, 1935, no recurrences; typical
erythema multiforme
4—4—36, had recurrences; no reaction
to drugs
3—21—36, ten attacks, typical cry-
thema multiforme.
47 6—12—33 Erythema multiforme
63 7—27—33 Bullous erythema multiforme
66 8—4—33 Erythema multiforme
111 2—13—34 Erythema multiforme
121 2—20—34 Erythema multiforme
135 4—6--34 Erythema multiforme
140 4-12-34 Erythema multiforme
143 4—18—34 Erythema multiforme
145 4—18—34 Pemphigus
162 5—31—34
188 7—19—34
194 7—31—34
225 9—1—34
244 10—19—34
251 11—21—34
254 12—10—34
261 12—27—34
263 1—3—35
267 1—12—35
270 1—17—35
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TABLE 4—Continued
CASE
DATE OEWRICB
PUESICIAN'S CLINICAL IMI'RESSION
SUBSEQUENT COURSE
_________
Group A—CoiUinued
277 2—4—35 Erythema multiforme 3—21—36, recurrence; spring and fall
attacks for six years.
283 2—20—35 Erythema multiforme 3—21—36, typical erythema multi-
forme; several previous attacks.
290 3—11—35 Erythema multiforme 4—20—36, typical attack of erythema
multiforme; 4—16—36, serum positive
with erythema multiforme antigen.
293 3—18—35 Erythema multiforme 3—24—36, having recurrences; typical
erythema multiforme
294 3—18—35 Erythema multiforme 3—9—36, recurrence; attacks for three
years typical erythema multiforme.
299 5—10-36 Erythema multiforme 4—1—36, typical erythema multiforme;
recurrent type.
338 5—2—35 Erythcma multiforme October, 1935, recurrence; typical
erythema multiforme.
355 6—18—35 Erythema multiforme 4—3—35, one recurrence; attacks spring
and fall for three years.
365 7—23—35 Erythema multiforme 3—31—36, typical bullous erythemamul-
tiforme; 1—4 attacks a year for eight
years.
370 8—1—35 Erythema multiforme 3—12—36, recurrence in mouth; many
recurrent attacks before test; clin-
ically erythema multiforme.
440 12—2—35 Erythema multiforme 6—2—36, typical erythema multiforme;
well then.
449 1—8—36 Erythema multiforme 6—2—36, typical erythema multiforme;
well then.
461 3—19—36 Erythema multiforme 5—25—36, clear; was typical erythema
multiforme; spring and fall attacks
for eight years.
484 4—20—36 Erythema multiforme Spring and fall attacks for four years;
typical erythema multiforme.
Group B. Serums which were obtained in cases in which a tentative diagnosis of cry-
thema multiforme was entertained but which produced negative tests with the erythema
multiforme antigen.
fiNAL DIAGNOSIS
129 Trichophytosis with bullous tn-
chophytid
224 Dermatitis medicamentosa (phenol-
phthalein)
237 Ulcerations of mouth—food sensi-
tivity
252 Trichophytosis with trichophytid of
the erythema multiforme type
255 Dermatitis medicamentosa
301 lododerma
333 Aphthous stomatitis
451 Dermatitis medicamentosa (veronal)
464 Tnichophytosis with trichophytid
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TABLE 4—Concluded
forme antigen.
Herpes zoster
Recurrent herpes
Pityriasis rosea
Herpes facialis
Discoid lupus ery-
thematosus
Dermatitis medica-
mentosa
Lichen planus
Infantile eczema
Infectious eczematoid
dermatitis
Pyoderma gangrenosum.
Pellagra
Angioneurotic edema....
Atopic eczema
Varicella
Urticaria
Cold allergy
Herpes gestationes
Normal persons
Erythema nodosuin
Eczema of hands
Contact dermatitis.
Seleroderma
Sarcoid
Acne Rosacea
Neurodermatitis
Hodgkin's disease
Summer prurigo
Aphthous stomatitis...
Beriberi
Malignant erythro.
derma
Thrush
Lymphatic leukemia...
Sprue
Bullous impetigo
Vincent's angina
Rosacea-like tubercu-
lid of Lewandow-
sky
Vesicular toxic cry-
thema—etiology un-
determined)
Recurrent vesicular
lesions of mouth and
penis (etiology un-
determined) 1
Dermatitis exfoliative
(venenata) 1
Ulcer of foot (etiology
undetermined) 1
Idiopathic exfoliative
dermatitis 1
Pemphigus 58
Dermatitis herpeti-
formis 55
Lupus erythematosus
(two recovered) 22
Cases in which clinical
diagnosis was not yet
definitely established
(In sixteen cases pem-
phigus was suspected
and in fifteen cases
dermatitis herpeti-
formis was suspected.) 31
eluded that the serums of patients who have chronic discoid lupus erythematosus
do not contain antibodies of the type demonstrable by this test (as usually run)
for the specific streptococcus isolated from patients who have lupus erythema-
tosus disseminatus or at least they do not contain them in sufficient titer to admit
of detection by this method in its present state of sensitiveness. This may be
interpreted as evidence that these two types of lupus erythematosus do not have
a common etiologic agent. However, this point needs further investigation,
since there is a very slight reaction at low dilutions of serum.
Analysis and consideration. of the results of this test as applied to erythema multiforme
In table 4 are recorded the results of this test, together with the available
clinical data, as it has been applied to erythema multiforme. Group A consists
of the serums obtained in thirty-four cases in which a definite clinical diagnosis
of erythema multiforme is established. A positive test was obtained with the
erythema multiforme antigen and the serum of each of these patients.
Group B consists of the serums obtained from nine cases in which the clinical
findings were those of erythema multiforme at the time the serum was drawn.
At this time a tentative diagnosis of erythema multiforme was considered.
Subsequently, these patients were all shown to be suffering from diseases with
established etiologic agents that distinguished them from the infectious type of
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Group C. Serums which were obtained in diseases distinct from erythema multiforme
and from normal persons, and which produced negative tests with the erythema multi-
9
4
5
2
9
5
4
3
3
1
2
1
17
4
2
1
5
8
1
1
2
4
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
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erythema multiforme. The serum of each of these patients produced a negative
test with erythema multiforme antigen and control antigens. It is an accepted
fact that the clinical picture of erythema multiforme may be produced by many
varied infectious and noninfectious agents. By the application of this test to
the serums of patients presenting the clinical findings of erythema multiforme,
it has thus been possible to distinguish between the so-called idiopathic or vernal
type of erythema multiforme and the erythema multiforme-like eruptions due
to sensitization to foods and drugs or those caused by other types of infections,
such as fungus infection.
Group C includes control serums obtained from 279 patients who were well
or who had cutaneous or systemic diseases distinct from erythema multiforme.
Some of the patients in this group had eruptions resembling erythema multiforme.
All of these serums produced negative tests with the erythema multiforme anti-
gen.
Positive tests were obtained with the serums in thirty-four cases (group A)
in which a definite clinical diagnosis of erythema multiforme was established.
Negative tests with the erythema multiforme antigen were obtained with the
serums in 288 patients. In nine of these cases (group B) eruptions which had
the morphology of erythema multiforme were present at the time the serums
were drawn. These eruptions were later found to be due to various causes,
which distinguished them from true erythema multiforme exudativum. In the
other 279 cases (group C) the serums were taken from patients who had cutaneous
or systemic diseases definitely distinct from erythema multiforme, and from well
persons.
COMMENT
It has been shown that the specific reduction of the cataphoretic mobility of
an organism that results from treatment of that organism with a serum, is the
result of the presence in that serum of antibodies specific for that organism
(10, 11, 12, 13, 14, 15 16). Therefore, the results of these tests may be in-
terpreted as indicative of the specificity of the respective streptococci isolated
from patients who had (1) pemphigus, (2) dermatitis herpetiformis, (3) lupus
erythematosus disseminatus, and (4) erythema multiforme exudativum. Hence,
this report of the results of these tests is made at this time to add support to the
previously presented evidence of the specificity of the respective streptococci
isolated from patients who had the four diseases named (1—5).
The use of this procedure as a differential diagnostic test for these four diseases
is at present impractical for wide application. This statthnent is based on the
fact that there are certain unstable influencing factors which still want of ade-
quate control. One of the greatest sources of difficulty in this regard is that, in
spite of all efforts to date, the antigens gradually deteriorate. Therefore, it is
necessary to have a constant source of fresh material from which new antigens
can be regularly obtained so that in a particular "set-up," antigens of approxi-
mately the same age may be used. Many advances in stabilization of these
antigens have been made and efforts directed toward this end will be continued.
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Another fact which has been responsible for a great amount of difficulty is that
fresh serums in most instances give unsatisfactory tests. Such serums usually
reduced equally to a slight or moderate degree the mobility of each of the four
antigens used and failed to show a specific marked action on the specific antigen.
In the case of most serums, after aging in the refrigerator for from seven to ten
days, this apparently inhibiting mechanism on the specific antibody disappeared
and tests performed after that time demonstrated the usual marked reduction
of the mobility of the specific antigen. Investigations have been started and
will be continued in an effort to establish a method of producing this effect of
aging in serums rapidly. Until methods of control of these and of other as yet
unstable features of this delicate test are worked out, it cannot be widely applied.
Long training in the reading of the test is necessary and a great personal factor
exists in this respect. It is to be hoped that investigations which have already
been started will lead to methods of control of the unstable influencing factors
to such a degree that this test can be adapted to wide usage.
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